Malignant tumors that invade the temporal bone are rare, and diagnosis and treatment are straightforward with few areas of controversy.
Watchful Waiting and OME
I would like to comment on your article Watchful Waiting May Be the Best Strategy, by Sheri Polley, in the November 2006 issue of ENToday.
Head and Neck Surgery: Meeting the Needs of the 21st Century
How can head and neck surgeons best meet the changing needs of patients and trainees in the 21st century?
Perioperative Steroids’ Effect on Surgery for Chronic Rhinosinusitis: the POSE Scoring System
Perioperative steroids have a clinically significant impact on the technical aspects of surgery and improve objective surgical outcomes in the short and medium term, according to research and a new scoring system presented April 26 by Triological Society Mosher Award recipient Erin D. Wright, MD, FRCSC, at the Combined Otolaryngology Spring Meetings.
Smokeless Tobacco and Health Effects: Cancer Specialists Weigh In
Since President Richard M. Nixon declared a war on cancer more than 30 years ago, the battle still rages on several fronts.
Exploring Links Between Smoking, Diet, and Oral Cancer Risk: What Should Be Message to Patients?
According to the American Cancer Society, smokers are six times more likely than nonsmokers to develop oral cavity and oropharyngeal cancers.
New Paradigms Emerging in Diagnosis, Management of Thyroid Cancer
A Swing of the Pendulum?
For years, radical surgery was the only treatment for head and neck cancer (HNSCC).
First Two Patients Respond to Gene Therapy in Melanoma Study
Gene therapy as a treatment for cancer has advanced from the theoretical to the possible: in a pilot study published in August in the journal Science, investigators reported that two of 17 patients with advanced melanoma responded to a treatment known as genetically engineered therapy.
FDA Advisory on Triptans and SSRI/SNRIs Will Not Affect Migraine Treatment, Say Experts
A new Food and Drug Administration (FDA) advisory warns that the combined use of triptans and selective serotonin reuptake inhibitors (SSRIs) or selective serotonin/norepinephrine reuptake inhibitors (SNRIs) may result in life-threatening serotonin syndrome, which occurs when the body has too much serotonin.